Follow The Filings

ECVT Ecovyst Inc.

Industrials, filed as ECOVYST INC (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Howard Marks sold out of Ecovyst.

Who owns ECVT

Sorted by value, long equity only, as of 2026 Q2.

History
Howard Marks, Oaktree Capital Management exited 2026 Q2 Last 2026 Q1 0.47% Exit −0.47% 2,393,791 $31M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ECVT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ECVT insider trades
  • $250K bought by 1 insider
  • $239K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Patti A. Humble Director
    Buy
    $250K 24,875 shares at $10.05 +273% to stake
    Traded Sep 10 Filed Sep 14
    ↗
  2. Sarah Lorance Director
    Sale
    $113K 8,450 shares at $13.33 13% of stake
    Traded Jun 2 Filed Jun 3
    ↗
  3. Susan F Ward Director
    Sale
    $126K 15,000 shares at $8.40 16% of stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 6 share withholdings for taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.01,2.04,5.02,9.01 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $691.12M $704.49M $723.52M
Gross profit $197.96M $201.52M $158.09M
Gross margin * 28.6% 28.6% 21.8%
Net income $71.15M -$6.65M -$71.13M
Net margin * 10.3% -0.9% -9.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $245.99M $303.71M $319.36M
Total non-current assets * $1.59B $1.5B $0.942B
Total assets $1.84B $1.8B $1.26B
Total current liabilities $119.08M $115.13M $120.82M
Total non-current liabilities * $1.01B $0.987B $0.537B
Total equity $705.46M $700.46M $603.44M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $137.6M $149.89M $140.3M
Cash from investing -$65.34M -$73.45M $435.41M
Cash from financing -$93.5M -$17.84M -$524.96M
Net change in cash -$22.56M $57.65M $51.18M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.